223 related articles for article (PubMed ID: 17452966)
1. Management of Graves' ophthalmopathy.
Wiersinga WM
Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):396-404. PubMed ID: 17452966
[TBL] [Abstract][Full Text] [Related]
2. The influence of prior hyperthyroidism on euthyroid graves' ophthalmopathy.
Termote K; Decallonne B; Mombaerts I
J Ophthalmol; 2014; 2014():426898. PubMed ID: 25045529
[TBL] [Abstract][Full Text] [Related]
3. Graves' ophthalmopathy: the clinical and psychosocial outcomes of different medical interventions - a systematic review.
Bello OM; Druce M; Ansari E
BMJ Open Ophthalmol; 2024 Jun; 9(1):. PubMed ID: 38886120
[TBL] [Abstract][Full Text] [Related]
4. Advances in artificial intelligence in thyroid-associated ophthalmopathy.
Yi C; Niu G; Zhang Y; Rao J; Liu G; Yang W; Fei X
Front Endocrinol (Lausanne); 2024; 15():1356055. PubMed ID: 38715793
[TBL] [Abstract][Full Text] [Related]
5. [Four perspectives on Graves' orbitopathy - from the point of view of the patient, general practitioner, endocrinologist, and ophthalmologist].
Filipsson Nyström H; Fellbrant K; Lundberg C; Botusan I; Åsman P; Träisk F
Lakartidningen; 2024 May; 121():. PubMed ID: 38775447
[TBL] [Abstract][Full Text] [Related]
6. Pediatric hyperthyroidism and thyroid eye disease management.
Adeoye O; Nwokeji I; Madu CT
J AAPOS; 2023 Dec; 27(6):382. PubMed ID: 37939915
[No Abstract] [Full Text] [Related]
7. Pediatric hyperthyroidism and thyroid eye disease management.
Li J; Austin J; Douglas RS; Nallasamy S
J AAPOS; 2023 Jun; 27(3):123-128. PubMed ID: 37182650
[No Abstract] [Full Text] [Related]
8. Update on the medical treatment of Graves' ophthalmopathy.
Griepentrog GJ; Garrity JA
Int J Gen Med; 2009 Dec; 2():263-9. PubMed ID: 20360911
[TBL] [Abstract][Full Text] [Related]
9. Misfortunes do not come in pairs in patients with active moderate-to-severe Graves' orbitopathy.
Sawicka-Gutaj N; Gruszczyński D; Zawalna N; Nijakowski K; Fichna M; Ruchała M
Pol Arch Intern Med; 2024 Jun; 134(6):. PubMed ID: 38856675
[No Abstract] [Full Text] [Related]
10. An unusual finding of giant fat-rich retroperitoneal masses in a patient with Graves' disease.
Yoshida H; Nakajima K; Hayashi H; Kimura S; Irie Y
Oxf Med Case Reports; 2020 Jul; 2020(7):omaa044. PubMed ID: 32728447
[TBL] [Abstract][Full Text] [Related]
11. Comment on: 'Effect of smoking on retrobulbar blood flow in thyroid eye disease'.
Çalışkan S; Acar M; Gürdal C
Eye (Lond); 2017 May; 31(5):814. PubMed ID: 27983730
[No Abstract] [Full Text] [Related]
12. Re: "Associations Between Thyroid Eye Disease and Glaucoma Among Those Enrolled in the National Institutes of Health All of Us Research Program".
Sidhu AS; Walker CEL; Al Yassin A; Xiradis N; Tweedie PJ; Kim D; Wong ELS; Lee MK; Tsoi AT; Fu MY; Ouyang MH; Gunasegaram J; Fatima A; Borchert G; Nguyen I; Agar A; Francis IC
Ophthalmic Plast Reconstr Surg; 2024 May-Jun 01; 40(3):356. PubMed ID: 38215458
[No Abstract] [Full Text] [Related]
13. Pathogenesis of Graves' ophthalmopathy: the role of autoantibodies.
Khoo TK; Bahn RS
Thyroid; 2007 Oct; 17(10):1013-8. PubMed ID: 17935483
[TBL] [Abstract][Full Text] [Related]
14. Current and Emerging Treatment Strategies for Graves' Orbitopathy.
Genere N; Stan MN
Drugs; 2019 Feb; 79(2):109-124. PubMed ID: 30659423
[TBL] [Abstract][Full Text] [Related]
15. Practical Guidelines Management of Graves Ophthalmopathy.
Subekti I; Soewondo P; Soebardi S; Darmowidjojo B; Harbuwono DS; Purnamasari D; Tarigan TJE; Wisnu W; Tahapary DL; Kurniawan F; Sidik M; Nusanti S; Dewiputri S; Suharko H; Suardana GG; Suroyo I; Wulani V; Siswoyo AD; Gondhowiardjo S; Kodrat H
Acta Med Indones; 2019 Oct; 51(4):364-371. PubMed ID: 32041923
[TBL] [Abstract][Full Text] [Related]
16. Graves' ophthalmopathy.
Bahn RS
N Engl J Med; 2010 Feb; 362(8):726-38. PubMed ID: 20181974
[TBL] [Abstract][Full Text] [Related]
17. Corticosteroids in Moderate-To-Severe Graves' Ophthalmopathy: Oral or Intravenous Therapy?
Penta L; Muzi G; Cofini M; Leonardi A; Lanciotti L; Esposito S
Int J Environ Res Public Health; 2019 Jan; 16(1):. PubMed ID: 30626069
[TBL] [Abstract][Full Text] [Related]
18. Current and Future Treatments for Graves' Disease and Graves' Ophthalmopathy.
Kotwal A; Stan M
Horm Metab Res; 2018 Dec; 50(12):871-886. PubMed ID: 30286486
[TBL] [Abstract][Full Text] [Related]
19. The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy.
Bartalena L; Baldeschi L; Boboridis K; Eckstein A; Kahaly GJ; Marcocci C; Perros P; Salvi M; Wiersinga WM;
Eur Thyroid J; 2016 Mar; 5(1):9-26. PubMed ID: 27099835
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
